温馨提示：本站仅提供公开网络链接索引服务，不存储、不篡改任何第三方内容，所有内容版权归原作者所有
AI智能索引来源：http://www.msd.com/company-overview
点击访问原文链接

Who we are - MSD

进入原网站 导航首页
Who we are - MSD Skip to content

Search everything Close Menu Close Main menu Company Who we are What we do Stories History Sustainability Sustainability overview Philanthropy MSD Medical Outreach Program Impact Venture Fund Transparency disclosures Sustainability resources Leadership Leadership overview Board of directors Executive team Culture & values Culture & values overview Code of conduct, ethics and compliance Diversity and inclusion Policies and positions Suppliers Suppliers overview Supplier registration Supplier help for Ariba Research Research overview Areas of focus Oncology Vaccines Infectious diseases Cardiovascular disease Immunology Neuroscience Ophthalmology Areas of innovation Data science and artificial intelligence Green and sustainable science Our therapeutic modalities Translational medicine Pipeline Business development and licensing Clinical Trials Clinical trials overview Diversity in clinical trials R&D locations How we invent Meet our scientists Publications Safety data sheets (SDS) Product patents Patients Patients overview Play an active role in your health care Fighting counterfeit medicine Media Media overview News releases Company statements Company fact sheet Investors Investors overview Events and presentations Stock information Careers Who we are Learn more Contact us What can we help you find? Search for: Who we are We aspire to be the premier research-intensive biopharmaceutical company. We’re at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals.

Our purpose: We use the power of leading-edge science to save and improve lives around the world

For more than 130 years, we’ve brought hope to humanity through the development of important medicines and vaccines. We foster an inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.

Our values | Diversity and inclusion | Leadership I Patients

Our values We hold ourselves to the highest standards of ethics and integrity.

We're driven by a desire to improve life Our values represent the core of our character and guide every decision and action we take.

Patients first Respect for people Ethics and integrity Innovation and scientific excellence Learn more about our culture and values × Diversity and inclusion We recognize the importance of embedding a culture of inclusion and belonging at every level of our company. We’re committed to fostering an environment of engagement and empowerment. 

We strive to provide equal opportunity for all An inclusive mindset is central to our business growth and enables us to ensure patients and customers experience ultimate health outcomes.

Learn more about our diversity and inclusion efforts × Leadership Our leaders guide our purpose to use the power of leading-edge science to save and improve lives around the world. This is the foundation of everything we do.

The team that guides our passion Our leaders come from all areas of the business to help position us to succeed.

Meet our leadership team × Patients and caregivers We work hard to bring you the medications and vaccines that help fight some of the world’s most serious health concerns.

Everything that motivates us starts with you We’re here to help you get the information you need to guide you on your health journey.

Learn more about our commitment to patients × Learn more about who we are Read our stories

Learn about the heartbeat of our company.

How wearable technology powers patient-focused drug development Our scientists are exploring the use of sensor-based technologies and digital clinical measures to improve disease understanding Our Q4 and full-year 2025 financial results MSD’s Q4 and full-year 2025 sales performance reflects strength across oncology and animal health, as well as increasing contributions from new launches. Our company announced Q4 worldwide sales of $16.4 billion. Full-year 2025 worldwide sales were $65.0 billion. “In 2025, we continued to advance leading-edge science to deliver transformative medicines and vaccines that are improving […] 5 ways we’re transforming artificial intelligence into impact We’re applying AI across our company to help us work smarter and faster so we can reach patients sooner Acting early in cancer detection Diagnosing cancer early, before it has spread, may potentially lead to better outcomes Previous Next What we do We use the power of leading-edge science to save and improve lives around the world.

Learn more

Related links Research We believe research is the will to conquer the impossible and that science will lead the way. Philanthropy Philanthropy is critical to helping us fulfill our company's commitment to improving access to health around the globe. Suppliers Economic inclusion, small business development and environmental sustainability are core to our procurement practices. Connect with us on social For patients and health care professionals MSD Manuals
Medical information source covering thousands of topics in all fields of medicine Clinical trials
Learn about our clinical trials and find available studies Sustainability Impact Report
Reporting on our commitment to operating responsibly to benefit society MSD for Mothers
An initiative to create a world where no woman has to die giving life About MSD MSD Animal Health
The global animal health business unit of MSD Contact Us
If you have a question or need more information about us, find out who you should contact. Forward-looking statementCookie policyCookie PreferencesPrivacyTerms of useAccessibilitySitemap Copyright © 2026 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved. Forward-looking statement of Merck & Co., Inc., Rahway, N.J., USA This news release of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept

智能索引记录